Skip to main content


Key publications-Faculty

De Veirman, K., Menu, E., Maes, K., De Beule, N., De Smedt, E., Maes, A., ... Van Valckenborgh, E. (2019). Myeloid-derived suppressor cells induce multiple myeloma cell survival by activating the AMPK pathway. Cancer Letters, 442, 233-241.

Maes, A., Maes, K., De Raeve, H., De Smedt, E., Vlummens, P., Szablewski, V., ... De Bruyne, E. (2019). The anaphase-promoting complex/cyclosome: a new promising target in diffuse large B-cell lymphoma and mantle cell lymphoma. British Journal of Cancer, 120(12), 1137-1146.

De Beck, L., Melhaoui, S., De Veirman, K., Menu, E., De Bruyne, E., Vanderkerken, K., ... Maes, K. (2018). Epigenetic treatment of multiple myeloma mediates tumor intrinsic and extrinsic immunomodulatory effects. OncoImmunology, 7(10), [e1484981].

Faict, S., Muller, J., De Veirman, K., De Bruyne, E., Maes, K., Vrancken, L., ... Menu, E. (2018). Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts. Blood Cancer Journal, 8(11), 105-105. [105].

De Smedt, E., Maes, K., Verhulst, S., Liu, H., Kassambara, A., Maes, A., ... De Bruyne, E. (2018). Loss of RASSF4 expression in multiple myeloma promotes RAS-driven malignant progression. Cancer Research, 78(5), 1155-1168.

Maes, K., Boeckx, B., Vlummens, P., De Veirman, K., Menu, E., Vanderkerken, K., ... De Bruyne, E. (2018). The genetic landscape of 5T models for multiple myeloma. Scientific Reports, 8(1), [15030].

De Veirman, K., De Beule, N., Maes, K., Menu, E., De Bruyne, E., De Raeve, H., ... Van Valckenborgh, E. (2017). Extracellular S100A9 protein in bone marrow supports multiple myeloma survival by stimulating angiogenesis and cytokine secretion. Cancer Immunology Research, 5(10), 839-846.

Favreau, M., Menu, E., Gaublomme, D., Vanderkerken, K., Faict, S., Maes, K., ... Elewaut, D. (2017). Leptin receptor antagonism of iNKT cell function: a novel strategy to combat multiple myeloma. Leukemia, 31(12), 2678-2685.

Frassanito, M., De Veirman, K., Desantis, V., Marzo, L. D., Vergara, D., Ruggieri, S., ... Vacca, A. (2016). Halting pro-survival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patients. Leukemia, 30(3), 640-648.

Wang, J., Hendrix, A., Hernot, S., Lemaire, M., De Bruyne, E., Van Valckenborgh, E., ... Menu, E. (2014). Bone marrow stromal cell-derived exosomes as communicators in drug resistance in multiple myeloma cells. Blood, 124(4), 555-566.

Maes, K., De Smedt, E., Lemaire, M., De Raeve, H., Menu, E., Van Valckenborgh, E., ... De Bruyne, E. (2014). The role of DNA damage and repair in decitabine-mediated apoptosis in multiple myeloma. Oncotarget, 5(10), 3115-3129.

De Bruyne, E., Bos, T., Schuit, F., Van Valckenborgh, E., Menu, E., Thorrez, L., ... Vanderkerken, K. (2010). IGF-1 suppresses Bim expression in multiple myeloma via epigenetic and posttranslational mechanisms. Blood, 115(12), 2430-2440.